|
Dr. Mills has served as the Corporate Vice President of Business Development and Chief Scientific Officer of Target Therapeutics, a medical device company that was acquired by Boston Scientific for $1.2 billion in 1997. He also served as the Director for Prograft Medical, a Target affiliate. Prior to joining Target in 1994, Dr. Mills served as Director of Business Development and Advanced Research & Development in the Interventional Cardiology Division of Baxter Healthcare. Dr. Mills received his Ph.D. in Bioengineering from the University of California, Berkeley & San Francisco School of Medicine, his M.S. in Electrical Engineering & Computer Science from the University of California, Berkeley, and his B.S. in Electrical Engineering from the University of Colorado, Boulder. | 